Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-16 23:06 | 2025-05-14 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $41.89 | 28,125 | $1,178,156 | 260,354 | -9.7% |
| 2025-04-11 23:05 | 2025-04-09 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $41.50 | 49,700 | $2,062,550 | 260,354 | -16.0% |
| 2025-03-14 23:07 | 2025-03-12 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $46.05 | 53,183 | $2,448,811 | 259,997 | -17.0% |
| 2024-11-16 00:05 | 2024-11-13 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $54.75 | 35,000 | $1,916,250 | 220,937 | -13.7% |
| 2024-10-18 23:05 | 2024-10-16 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $40.86 | 35,000 | $1,430,100 | 220,937 | -13.7% |
| 2024-09-13 23:05 | 2024-09-11 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $43.64 | 35,000 | $1,527,225 | 220,937 | -13.7% |
| 2024-08-16 23:05 | 2024-08-14 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $45.71 | 35,000 | $1,599,675 | 220,937 | -13.7% |
| 2024-07-19 23:05 | 2024-07-17 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $51.48 | 35,000 | $1,801,625 | 220,937 | -13.7% |
| 2024-06-14 23:05 | 2024-06-12 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $43.61 | 35,000 | $1,526,350 | 220,752 | -13.7% |
| 2024-05-17 23:05 | 2024-05-15 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $48.76 | 35,000 | $1,706,600 | 220,752 | -13.7% |
| 2024-04-19 23:05 | 2024-04-17 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $45.53 | 35,000 | $1,593,550 | 195,307 | -15.2% |
| 2024-03-15 23:07 | 2024-03-13 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $44.35 | 35,000 | $1,552,075 | 194,870 | -15.2% |
| 2024-02-17 00:05 | 2024-02-14 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $47.92 | 35,000 | $1,677,200 | 174,008 | -16.7% |
| 2024-01-20 00:06 | 2024-01-17 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $38.28 | 33,452 | $1,280,375 | 169,985 | -16.4% |
| 2023-12-16 00:05 | 2023-12-13 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $35.58 | 24,000 | $853,800 | 169,985 | -12.4% |
| 2023-12-09 00:05 | 2023-12-06 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $34.14 | 24,397 | $832,909 | 176,742 | -12.1% |
| 2023-01-13 00:11 | 2023-01-10 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $27.13 | 39,938 | $1,083,598 | 157,066 | -20.3% |
| 2021-04-20 23:15 | 2021-04-19 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $58.01 | 40,000 | $2,320,204 | 142,973 | -21.9% |
| 2021-03-30 23:50 | 2021-03-29 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $51.01 | 40,000 | $2,040,252 | 167,550 | -19.3% |
| 2021-03-03 00:15 | 2021-03-01 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $48.11 | 40,000 | $1,924,228 | 207,550 | -16.2% |
| 2019-10-03 23:03 | 2019-10-01 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $14.88 | 58,125 | $864,650 | 112,783 | -34.0% |
| 2018-11-09 00:02 | 2018-11-06 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $15.39 | 50,000 | $769,500 | 75,163 | -39.9% |
| 2018-10-09 23:03 | 2018-10-04 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $15.02 | 75,000 | $1,126,500 | 75,163 | -49.9% |
| 2018-05-18 23:00 | 2018-05-16 | VCEL | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $14.01 | 28,886 | $404,603 | 73,559 | -28.2% |
| 2014-09-18 00:16 | 2014-09-16 | ASTM | Vericel Corp | Colangelo Dominick | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | BUY | $2.55 | 20,000 | $51,000 | 20,000 | +100.0% |
| 2008-02-13 01:01 | 2008-02-08 | OSCI | N/A | Colangelo Dominick | Officer; EVP Corporate Dev & Operations | Other | BUY | $1.24 | 2,000 | $2,479 | 31,797 | +6.7% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.